FR2706143B1
(en)
|
1993-06-07 |
1995-08-11 |
Oreal |
Method for molding a makeup composition and makeup product obtained.
|
CA2197982C
(en)
*
|
1994-08-04 |
2010-03-23 |
Bruce Joseph Roser |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US5582591A
(en)
*
|
1994-09-02 |
1996-12-10 |
Delab |
Delivery of solid drug compositions
|
US5595760A
(en)
*
|
1994-09-02 |
1997-01-21 |
Delab |
Sustained release of peptides from pharmaceutical compositions
|
US5837276A
(en)
*
|
1994-09-02 |
1998-11-17 |
Delab |
Apparatus for the delivery of elongate solid drug compositions
|
US6964771B1
(en)
|
1995-06-07 |
2005-11-15 |
Elan Drug Delivery Limited |
Method for stably incorporating substances within dry, foamed glass matrices
|
FR2756493B1
(en)
*
|
1996-12-02 |
2001-04-13 |
Delab |
DEVICE FOR LOCAL ADMINISTRATION OF SOLID OR SEMI-SOLID FORMULATIONS
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
FR2781667B1
(en)
*
|
1998-07-30 |
2001-06-01 |
Oreal |
COSMETIC, PHARMACEUTICAL, OR DERMATOLOGICAL PATCH
|
US6623751B2
(en)
|
1998-07-30 |
2003-09-23 |
L'oreal S.A. |
Cosmetic, pharmaceutical, or dermatological patch
|
US20030007991A1
(en)
*
|
1998-09-25 |
2003-01-09 |
Masters David B. |
Devices including protein matrix materials and methods of making and using thereof
|
US7662409B2
(en)
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
FR2770134B1
(en)
*
|
1998-10-28 |
2002-06-07 |
Delab |
SOLID OR SEMI-SOLID FORMULATIONS FOR LOCAL ADMINISTRATION
|
US6485453B1
(en)
|
1999-04-16 |
2002-11-26 |
Novo Nordisk A/S |
Cassette for storing and insertion of solid medicine
|
AU3957400A
(en)
|
1999-04-16 |
2000-11-02 |
Novo Nordisk A/S |
Dry, mouldable drug formulation
|
AU3803400A
(en)
*
|
1999-04-16 |
2000-11-02 |
Novo Nordisk A/S |
Cassette for storing and insertion of solid medicine
|
BR0000426B1
(en)
*
|
2000-01-28 |
2014-09-30 |
Biolab Sanus Farmaceutica Ltda |
PHARMACEUTICAL COMPOSITION
|
BR0001144B1
(en)
*
|
2000-02-21 |
2013-10-22 |
|
PHARMACEUTICAL COMPOSITION OF VITAMIN-E, PAPAINE AND HYALURONIDASE-BASED DICLOPHENAC
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
FR2822711B1
(en)
|
2001-03-28 |
2003-06-13 |
Oreal |
TREATMENT DEVICE COMPRISING AN ENVELOPE DEFINING A CAVITY IN WHICH A PART OF THE BODY MAY BE ENGAGED
|
US7615234B2
(en)
|
2001-09-11 |
2009-11-10 |
Glide Pharmaceutical Technologies Limited |
Drug delivery technology
|
GB2391480B
(en)
|
2002-08-05 |
2007-02-28 |
Caretek Medical Ltd |
Drug delivery system
|
GB2404865B
(en)
|
2001-09-11 |
2005-09-28 |
Caretek Medical Ltd |
Novel drug delivery technology
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
ATE508735T1
(en)
|
2001-12-19 |
2011-05-15 |
Novartis Ag |
PULMONARY ADMINISTRATION OF AMINOGLYCOSIDES
|
JP2008501037A
(en)
*
|
2004-06-01 |
2008-01-17 |
マイクロチップス・インコーポレーテッド |
Devices and methods for measuring and enhancing transport of drugs or analytes to / from medical implants
|
GB2422784A
(en)
|
2005-02-07 |
2006-08-09 |
Caretek Medical Ltd |
Disposable assembly comprising a needle or stylet
|
GB2446780A
(en)
|
2007-02-22 |
2008-08-27 |
Glide Pharmaceutical Technolog |
An elongate parenteral injection body having an injection point of angle 10 to 40 degrees.
|
AU2014253541B2
(en)
*
|
2007-02-22 |
2016-07-28 |
Glide Pharmaceutical Technologies Limited |
Solid pharmaceutical and vaccine dose
|
EP3466438A1
(en)
|
2009-08-03 |
2019-04-10 |
Incube Labs, Llc |
Swallowable capsule and method for stimulating incretin production within the intestinal tract
|
ES2362525B8
(en)
|
2009-10-08 |
2013-01-03 |
Azurebio, S.L. |
Medication formulation in the form of penetrating percutaneous needles.
|
EP2515992B1
(en)
*
|
2009-12-24 |
2018-10-10 |
Rani Therapeutics, LLC |
Swallowable drug delivery device
|
US8562589B2
(en)
|
2009-12-24 |
2013-10-22 |
Rani Therapeutics, Llc |
Swallowable drug delivery device and method of delivery
|
US8980822B2
(en)
|
2010-12-23 |
2015-03-17 |
Rani Therapeutics, Llc |
Therapeutic agent preparations comprising pramlintide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US8969293B2
(en)
|
2010-12-23 |
2015-03-03 |
Rani Therapeutics, Llc |
Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US8734429B2
(en)
|
2010-12-23 |
2014-05-27 |
Rani Therapeutics, Llc |
Device, system and methods for the oral delivery of therapeutic compounds
|
US9283179B2
(en)
|
2010-12-23 |
2016-03-15 |
Rani Therapeutics, Llc |
GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US8846040B2
(en)
|
2010-12-23 |
2014-09-30 |
Rani Therapeutics, Llc |
Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9629799B2
(en)
|
2010-12-23 |
2017-04-25 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9861683B2
(en)
|
2010-12-23 |
2018-01-09 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9402807B2
(en)
|
2010-12-23 |
2016-08-02 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US8809269B2
(en)
|
2010-12-23 |
2014-08-19 |
Rani Therapeutics, Llc |
Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US10639272B2
(en)
|
2010-12-23 |
2020-05-05 |
Rani Therapeutics, Llc |
Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9402806B2
(en)
|
2010-12-23 |
2016-08-02 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9284367B2
(en)
|
2010-12-23 |
2016-03-15 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9415004B2
(en)
|
2010-12-23 |
2016-08-16 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
US9259386B2
(en)
|
2010-12-23 |
2016-02-16 |
Rani Therapeutics, Llc |
Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
AU2012275112B2
(en)
*
|
2011-06-29 |
2017-07-06 |
Rani Therapeutics, Llc |
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
|
EP2726141B1
(en)
*
|
2011-06-29 |
2019-12-25 |
Rani Therapeutics, LLC |
Device for the oral delivery of therapeutic compounds
|
GB201307262D0
(en)
*
|
2013-04-23 |
2013-05-29 |
Chowdhury Dewan F H |
Device for containment and release of drug formulation
|
GB2545880A
(en)
|
2015-10-20 |
2017-07-05 |
Glide Pharmaceutical Tech Ltd |
Solid formulation
|